International journal of dermatology and venereology最新文献

{"title":"Erratum: Epidemiology of Genital Chlamydial Infection in China in 2019: Erratum.","authors":"","doi":"10.1097/JD9.0000000000000112","DOIUrl":"10.1097/JD9.0000000000000112","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1097/JD9.0000000000000099.].</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"6 2","pages":"86"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/b8/jd9-6-086.PMC10309094.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9800313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recalcitrant Cutaneous Mastocytosis Treated With Genetically Informed Targeted Therapy: A Case Report.","authors":"Laura Gleason,&nbsp;Volkan Tekmen,&nbsp;Alexa Cohen,&nbsp;Safiyyah Bhatti,&nbsp;Burcu Beksac,&nbsp;Jisun Cha,&nbsp;Pierluigi Porcu,&nbsp;Neda Nikbakht","doi":"10.1097/JD9.0000000000000243","DOIUrl":"https://doi.org/10.1097/JD9.0000000000000243","url":null,"abstract":"<p><p>Mastocytosis, a clonal proliferation of mast cells commonly involving the skin and bone marrow, has a varied clinical presentation ranging from cutaneous lesions to systemic disease. Cutaneous mastocytosis is managed symptomatically, but systemic mastocytosis is treated with targeted therapy against the mutated receptor tyrosine kinase c-KIT, the pathogenic driver of mastocytosis. However, there are no guidelines for the treatment of cutaneous mastocytosis refractory to symptomatic management. We herein report a method to select genetically informed therapy for symptomatic and recalcitrant cutaneous mastocytosis.</p><p><strong>Case presentation: </strong>We performed a mutational analysis of dermal mast cells after enrichment by laser capture in a 23-year-old woman with recalcitrant cutaneous mastocytosis. The analysis revealed a aspartic acid to valine substitution at codon 816 (D816V) mutation in the protein c-KIT. Based on these results, we initiated treatment with the multi-kinase/KIT inhibitor midostaurin, a treatment effective against the D816V c-KIT mutation. After 3 months of treatment, the patient exhibited a reduction in the number and size of cutaneous lesions and reported resolution of pruritus and decreased severity of other mast cell-related symptoms.</p><p><strong>Discussion: </strong>The treatment of mastocytosis relies heavily on whether the disease is limited to the skin or systemic. However, there are no guidelines for cutaneous mastocytosis that does not respond to symptomatic management. In the present report describing a patient with recalcitrant cutaneous mastocytosis, we describe a strategy in which skin mutational analysis is used to guide the selection of targeted therapy.</p><p><strong>Conclusion: </strong>Performing mast cell mutational analyses in the skin provides a means to select targeted therapy for symptomatic and refractory cutaneous mastocytosis.</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"6 2","pages":"107-109"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/6a/jd9-6-107.PMC10309087.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum: Nicolau Syndrome Following Metamizole Injection: A Case Report: Erratum.","authors":"","doi":"10.1097/JD9.0000000000000158","DOIUrl":"https://doi.org/10.1097/JD9.0000000000000158","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1097/JD9.0000000000000102.].</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"6 2","pages":"117"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/ca/jd9-6-117.PMC10309092.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9800310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Causal Variants of the GJB6 Gene are Associated with Hearing Loss and Skin Manifestations: A Case Report from Turkey: Erratum","authors":"","doi":"10.1097/jd9.0000000000000308","DOIUrl":"https://doi.org/10.1097/jd9.0000000000000308","url":null,"abstract":"This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"83 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135792580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Monitoring of Serum TWEAK Level Guides Glucocorticoid Dosages in the Treatment of Systemic Lupus Erythematosus","authors":"Jing-Yun Chen, Yu-Fei Zhang, Yi Wu, Xiao-Kang Wu, Li Wang, Mai Luo, Sheng-Xiang Xiao, Hui-Xia Wang, Yu-Min Xia","doi":"10.1097/jd9.0000000000000294","DOIUrl":"https://doi.org/10.1097/jd9.0000000000000294","url":null,"abstract":"Objective: Accurate assessment of systemic lupus erythematosus (SLE) disease activity is critical. This study explored the relationship between the serum level of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score as well as the role of TWEAK in guiding the glucocorticoid dosage in SLE treatment. Methods: This study involved 131 patients with SLE, 34 with subacute cutaneous lupus erythematosus (SCLE), 22 with discoid lupus erythematosus (DLE), and 32 healthy volunteers. The serum and urinary TWEAK levels were determined. Monomeric C-reactive protein (mCRP), anti-dsDNA IgG, antinuclear antibody (ANA), complements in serum and urinary albumin level were measured. The SLEDAI 2000 (SLEDAI-2K) was used to evaluate disease activity. The correlation of the SLEDAI-2K score with all biomarkers was determined. Methylprednisolone was orally administered to patients with SLE depending on the serum level of TWEAK. Results: TWEAK levels were higher in patients with SLE or SCLE than in patients with DLE or healthy controls. The serum TWEAK level was positively correlated with the SLEDAI-2K score in patients with SLE (P < 0.001), and was more strongly correlated with the SLEDAI-2K score than other parameters (P < 0.001). Moreover, TWEAK-based glucocorticoid therapy was associated with lower SLEDAI-2K scores, better tapering of glucocorticoid doses, and fewer lupus flares in patients with SLE. Conclusions: Serum TWEAK is a useful biomarker reflecting SLE disease activity. Monitoring of the serum TWEAK level can improve the outcomes of glucocorticoid therapy in patients with SLE.","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136334576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acknowledgments","authors":"","doi":"10.1097/jd9.0000000000000295","DOIUrl":"https://doi.org/10.1097/jd9.0000000000000295","url":null,"abstract":"","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"106 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135288922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biofilm Alterations on the Stepwise Acquisition of Fluconazole-resistant <i>Candida Albicans</i> Isolates.","authors":"Na-Na Song,&nbsp;Guan-Yu Qian,&nbsp;Hai-Lin Zheng,&nbsp;Xiao-Wei Zhou,&nbsp;Huan Mei,&nbsp;Dong-Mei Li,&nbsp;Xiao-Fang Li,&nbsp;Wei-Da Liu","doi":"10.1097/JD9.0000000000000223","DOIUrl":"https://doi.org/10.1097/JD9.0000000000000223","url":null,"abstract":"<p><p>By assessing and comparing the phenotypic changes on the stepwise acquisition of fluconazole resistant <i>Candida albicans</i> isolates, we could find and describe the relationship between drug resistance and biofilm formation ability in a series of clonal strains.</p><p><strong>Methods: </strong>We performed antifungal susceptibility of five drugs (fluconazole, itraconazole, voriconazole, caspofungin and amphotericin B) to further verify the antifungal activity of the six isolates <i>in vitro</i>. Then we combined hyphal formation assay, cell surface hydrophobicity test positively related to adherence ability, and biofilm assays <i>in vitro</i> to observe and compare the phenotypic characteristics of our six clonal strains.</p><p><strong>Results: </strong>Biofilm capability is enhanced for four drug- intermediate strains, whereas the initial susceptible strain and the final resistant strain are both poor in adherence, hyphal growth and biofilm formation.</p><p><strong>Conclusions: </strong>It was suggested that the biofilm formation ability were not absolutely related to the degree of fluconazole resistance.</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"5 3","pages":"132-139"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fd/e6/jd9-5-132.PMC9521591.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33490490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy.","authors":"Bahar Dasgeb,&nbsp;Youssefian Leila,&nbsp;Amir Hossein Saeidian,&nbsp;Jun Kang,&nbsp;Wenyin Shi,&nbsp;Elizabeth Shoenberg,&nbsp;Adam Ertel,&nbsp;Paolo Fortina,&nbsp;Hassan Vahidnezhad,&nbsp;Jouni Uitto","doi":"10.1097/JD9.0000000000000170","DOIUrl":"https://doi.org/10.1097/JD9.0000000000000170","url":null,"abstract":"<p><strong>Objective: </strong>Well-defined germ-line mutations in the <i>PTCH1</i> gene are associated with syndromic multiple basal cell carcinomas (BCCs). Here, we used whole exome sequencing (WES) to identify the role of patched-1 in patients with multiple, unusually large BCCs.</p><p><strong>Methods: </strong>A 72-year old patient presenting with numerous BCCs progressing to large ulcerating lesions was enrolled. WES was used to identify the pathogenic gene locus.</p><p><strong>Results: </strong>Genetic work-up by WES identified a homozygous <i>PTCH1</i> nonsense mutation in the tumor tissue but not present in her blood cells or in non-lesional skin. In addition, heterozygous missense mutations were identified in three cancer-associated genes (<i>EPHB2, RET</i>, and <i>GALNT12</i>) in blood cells as well as in lesional and non-lesional skin. We also tested systemic immune therapy as a potentially beneficial approach to treat patients with numerous large BCCs on scatted areas of involvement. A rapid and sustained response to nivolumab was noted, suggesting that it is an efficacious drug for long-term therapeutic outcome.</p><p><strong>Conclusion: </strong><i>PTCH1</i>, <i>EPHB2, RET</i>, and <i>GALNT12</i> may potentially contribute to the synergistic oncogene driven malignant transformation manifesting as multiple, unusually large BCCs.</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"4 2","pages":"70-75"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/80/ijdv-4-070.PMC8265835.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9784613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Kidney Stones are Prevalent in Individuals with Pseudoxanthoma Elasticum, a Genetic Ectopic Mineralization Disorder.","authors":"Douglas Ralph,&nbsp;Rina Allawh,&nbsp;Ian F Terry,&nbsp;Sharon F Terry,&nbsp;Jouni Uitto,&nbsp;Qiaoli Li","doi":"10.1097/jd9.0000000000000126","DOIUrl":"https://doi.org/10.1097/jd9.0000000000000126","url":null,"abstract":"<p><p>Pseudoxanthoma elasticum (PXE) is a rare genetic disorder caused by loss-of-function mutations in the <i>ABCC6</i> gene. While PXE is characterized by ectopic mineralization of connective tissues clinically affecting the skin, eyes, and cardiovascular system, kidney stones were reported in some individuals with PXE. The aim of this study is to determine whether kidney stones are an incidental finding or a frequent manifestation of PXE. We investigated the genetic basis of two siblings diagnosed with PXE. The younger patient presented with recurrent kidney stones since age 8. To address whether kidney stones are associated with PXE, the prevalence of kidney stones in a survey cohort of 563 respondents with PXE was compared to that of a general U.S. population survey, NHANES (National Health and Nutrition Examination Survey), with 28,629 participants. Genetic analysis in both patients identified compound heterozygous mutations in <i>ABCC6</i>, c.2787+1G>T and c.3774_3775insC. The analysis of participants aged 20 and older revealed that 23.4% of PXE patients had previously had a kidney stone, a significant increase compared to 9.2% in the general population. In addition, 17.8% of PXE patients reported their first kidney stone episode before age 18. PXE correlates with an increased risk of developing kidney stones with considerable morbidity and health-care cost.</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"3 4","pages":"198-204"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680818/pdf/nihms-1745159.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39601162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atherogenic Diet Accelerates Ectopic Mineralization in a Mouse Model of Pseudoxanthoma Elasticum.","authors":"Jing-Yi Zhao,&nbsp;Joshua Kingman,&nbsp;Ida Joely Jacobs,&nbsp;Jouni Uitto,&nbsp;Yi Cao,&nbsp;Qiao-Li Li","doi":"10.1097/JD9.0000000000000086","DOIUrl":"https://doi.org/10.1097/JD9.0000000000000086","url":null,"abstract":"<p><strong>Objective: </strong>Pseudoxanthoma elasticum (PXE) is a multisystem heritable disorder caused by mutations in the <i>Abcc6</i> gene. The disease is characterized by ectopic mineralization of the skin, eyes, and arterial blood vessels. Previous studies have suggested that cardiovascular complications in patients with PXE are caused in part by premature atherosclerosis. The aim of this study is to determine the effect of an atherogenic diet on ectopic mineralization.</p><p><strong>Methods: </strong>We used <i>Abcc6</i> ^{<i>tm1JfK</i>} mice (<i>Abcc6</i> ^<i>-/-</i> mice) as an established preclinical model of PXE. The offspring at age of 4 weeks were divided into two groups and fed the standard control laboratory diet (control group) and the atherogenic diet. Serum lipid profiles and bile acids were measured, and steatosis and tissue mineralization were evaluated by histopathologic analysis and chemical calcium quantification assay, respectively.</p><p><strong>Results: </strong>After 50-58 weeks of feeding an atherogenic diet, the concentrations of total cholesterol, low-density lipoprotein/very-low-density lipoprotein cholesterol, and bile acids were significantly higher in the <i>Abcc6</i> ^<i>-/-</i> mice on the atherogenic diet (180.9 ± 14.8 g/L, 145.9 ± 12.9 g/L, and 9.7 ± 1.4 μmol/L, respectively) than in <i>Abcc6</i> ^<i>-/-</i> mice on a control diet (85.2 ± 4.8 g/L, 25.1 ± 5.5 g/L, and 3.3 ± 0.5 μmol/L, respectively) (<i>P</i> < 0.001). Hypercholesterolemia was accompanied by extensive lipid accumulation in the liver and aorta, a characteristic feature of steatosis. The direct calcium assay demonstrated significantly increased mineralization of the muzzle skin containing the dermal sheath of vibrissae (57.2 ± 4.4 μmol Ca/gram tissue on the atherogenic diet and 43.9 ± 2.2 μmol Ca/gram tissue on control diet; <i>P</i> < 0.01), a reproducible biomarker of the ectopic mineralization process in these mice. An increased frequency of mineralization was also observed in the kidneys and eyes of mice on the atherogenic diet (<i>P</i> < 0.01).</p><p><strong>Conclusion: </strong>These observations suggest that the atherogenic diet caused hypercholesterolemia and accelerated ectopic mineralization in the <i>Abcc6</i> ^<i>-/-</i> mice. Our findings have clinical implications for patients with PXE, a currently intractable disorder with considerable morbidity and occasional mortality.</p>","PeriodicalId":73440,"journal":{"name":"International journal of dermatology and venereology","volume":"3 2","pages":"91-96"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/JD9.0000000000000086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38374038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}